Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metformin use and mortality among patients with diabetes and atherothrombosis.
Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC Jr, Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Roussel R, et al. Among authors: marre m. Arch Intern Med. 2010 Nov 22;170(21):1892-9. doi: 10.1001/archinternmed.2010.409. Arch Intern Med. 2010. PMID: 21098347
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
Roussel R, Hadjadj S, Pasquet B, Wilson PW, Smith SC Jr, Goto S, Tubach F, Marre M, Porath A, Krempf M, Bhatt DL, Steg PG. Roussel R, et al. Among authors: marre m. Int J Cardiol. 2013 Aug 20;167(4):1380-4. doi: 10.1016/j.ijcard.2012.04.019. Epub 2012 May 4. Int J Cardiol. 2013. PMID: 22560911
Interaction between diabetes and a high ankle-brachial index on mortality risk.
Potier L, Roussel R, Labreuche J, Marre M, Cacoub P, Röther J, Wilson PW, Goto S, Bhatt DL, Steg PG; REACH Investigators. Potier L, et al. Among authors: marre m. Eur J Prev Cardiol. 2015 May;22(5):615-21. doi: 10.1177/2047487314533621. Epub 2014 Apr 29. Eur J Prev Cardiol. 2015. PMID: 24781202
Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.
El Khoury P, Roussel R, Fumeron F, Abou-Khalil Y, Velho G, Mohammedi K, Jacob MP, Steg PG, Potier L, Ghaleb Y, Elbitar S, Ragot S, Andreata F, Caligiuri G, Hadjadj S, Boileau C, Marre M, Abifadel M, Varret M, Hansel B. El Khoury P, et al. Among authors: marre m. Diabetes Obes Metab. 2018 Apr;20(4):943-953. doi: 10.1111/dom.13181. Epub 2018 Jan 14. Diabetes Obes Metab. 2018. PMID: 29205760 Clinical Trial.
Severe hypoglycemia and risks of vascular events and death.
Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S; ADVANCE Collaborative Group. Zoungas S, et al. Among authors: marre m. N Engl J Med. 2010 Oct 7;363(15):1410-8. doi: 10.1056/NEJMoa1003795. N Engl J Med. 2010. PMID: 20925543 Free article. Clinical Trial.
Prediction of kidney-related outcomes in patients with type 2 diabetes.
Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, Zoungas S, Cass A, Patel A, Marre M, Mancia G, Mogensen CE, Poulter N, Chalmers J; ADVANCE Collaborative Group. Jardine MJ, et al. Among authors: marre m. Am J Kidney Dis. 2012 Nov;60(5):770-8. doi: 10.1053/j.ajkd.2012.04.025. Epub 2012 Jun 12. Am J Kidney Dis. 2012. PMID: 22694950
594 results